|
What medical condition is most commonly cited as the reason for using medical marijuana? |
|
|
|
|
Have the results of studies conducted between 2003-2017 indicated that cannabinoids are effective at treating chronic non-cancer pain? |
|
|
|
|
Epidemiological studies indicate that as many as 15% of inflammatory bowel disease (IBD) patients may use cannabinoids to ameliorate some of their symptoms, including improvement in diarrhea, abdominal pain and appetite. Do the studies show that cannabinoids are effective? |
|
|
|
|
The findings of multiple RCTs indicate that cannabinoids effectively treat chronic pain. Do cannabinoids effectively treat the chronic pain associated with fibromyalgia? |
|
|
|
|
Some cancer patients use medical marijuana to treat various cancer-associated ailments. What are some of the ailments ameliorated by medical marijuana? |
|
|
|
|
Side effects of short-term cannabinoid-based therapy may differ from person to person, and the same person may experience different side effects at different times. What factors influence the probability and the severity of adverse events? |
|
|
|
|
According to the results of a survey of breast cancer patients’ use of cannabinoid products before, during, and after treatment, 42% of survey participants had used medical cannabinoid products to relieve symptoms. What symptoms were treated with the cannabinoid products? |
|
|
|
|
Other than feeling “high” what are some of the reported psychological CNS-related side effects associated with cannabinoid use? |
|
|
|
|
Are cannabinoids an effective analgesic agent in the chronic pain setting? |
|
|
Only have a minute but want to Learn something every day®? Sign up to receive The Answer of the Day, bringing featured content from our course library right to your inbox each day.
TheAnswerPage Announces Our New CBD in Clinical Care Course
TheAnswerPage was launched in 1998 to provide daily education to healthcare providers in training and in practice.
Jeffrey Sherwood Block, M.D. . is a Board-certified physician anesthesiologist and adjunct Professor at the University of Miami Miller School of Medicine. Additionally, he is a highly awarded horticulturist and certified Master Gardener educator with the University of Florida’s UF/IFAS Extension Program. Dr. Block’s textbook chapter “Endocannabinoid Receptors and Medical Cannabis” (Advanced Therapeutics in Pain Medicine – CRC Press 2020) is a sentinel work on integrated pain management. Block served as the Florida Medical Association’s “Designated Expert on Botanical Medicines” authoring mandated physician education; and in 2014 was appointed by Florida’s Surgeon General to determine the rules for Florida’s first cannabis law. His consultancy’s demonstrated insight and responsible leadership are valued by both allied professionals and new industries seeking knowledge of future uses for Cannabinoid medicines.